Prof. André Vis, a urologist at VUMC in Amsterdam, the Netherlands, presented...
The Phase III IMpower010 trial successfully demonstrated that the addition of...
Patients with KRAS G12C-mutated advanced NSCLC often experience brain...
PD-1 and TIGIT play a significant role in the immunosuppressive response of T...
Results from the PEARLS/KEYNOTE-091 study, a triple-blind phase 3 trial, have...
The CheckMate 816 study has demonstrated that neoadjuvant nivolumab +...
Individuals diagnosed with oligometastatic NSCLC can benefit from local...
Divya Natesan from the University of Pittsburgh sought to examine the frequency...
Prof Dr Cora Sternberg shared her findings from the SAUL study. This study...
With their combined knowledge and experience, Prof. Paul Clement and Prof....